|
|
Baxter International Inc (BAX) |
|
|
|
| |
Baxter International Inc 's Long Term Debt to Equity
BAX's quarterly Long Term Debt to Equity and Long Term Debt, Equity growth
Due to long-term debt repayement of -5.91% Baxter International Inc improved Long Term Debt to Equity in second quarter 2024 to 1.35, above the Baxter International Inc 's average Long Term Debt to Equity.
Within Medical Equipment & Supplies industry in the second quarter 2024, 42 other companies have achieved lower Long Term Debt to Equity than Baxter International Inc in the II Quarter 2024. While Long Term Debt to Equity total ranking has improved so far in the second quarter 2024 to 1168, from total ranking in the first quarter 2024 at 1751 .
Explain Long Term Debt to Equity Ratio?
How much Long Term Debt BAX´s has?
What is the structure of BAX´s Equity?
|
Select the Comparisons :
|
|
Select the Ratio:
|
Long Term Debt to Equity ▼
|
Long Term Debt to Equity ▼
|
| BAX Long Term Debt to Equity |
(Jun 30 2024)
II. Quarter |
(Mar 31 2024)
I. Quarter |
(Dec 31 2023)
IV. Quarter |
(Sep 30 2023)
III. Quarter |
(Jun 30 2023)
II. Quarter |
| Y / Y Equity Change |
36.89 % |
38.61 % |
43.65 % |
46.37 % |
-36.75 % |
| Y / Y Long Term Debt Change |
-27.05 % |
-27.4 % |
- |
-12.91 % |
- |
| Long Term Debt to Equity MRQ |
1.35 |
1.35 |
1.31 |
1.72 |
2.54 |
| BAX's Total
Ranking |
# 1168 |
# 1751 |
# 268 |
# 1244 |
# 2488 |
| Seq. Equity Change |
-6.4 % |
-2.75 % |
3.7 % |
45.02 % |
-5.22 % |
| Seq. Long Term Debt Change |
-5.91 % |
-0.34 % |
-20.88 % |
-1.67 % |
-6.36 % |
| Long Term Debt to Equity second quarter 2024 Company Ranking |
| Within: |
No. |
| Medical Equipment & Supplies Industry |
# 43 |
| Healthcare Sector |
# 120 |
| Overall Market |
# 1168 |
| Long Term Debt to Equity Statistics |
| High |
Average |
Low |
| 2.9 |
0.78 |
0.23 |
| (Sep 30 2022) |
|
(Mar 31 2016) |
Cumulative Baxter International Inc 's Long Term Debt to Equity
BAX's Long Term Debt to Equity for the trailling 12 Months
BAX Long Term Debt to Equity |
(Jun 30 2024)
II. Quarter |
(Mar 31 2024)
I. Quarter |
(Dec 31 2023)
IV. Quarter |
(Sep 30 2023)
III. Quarter |
(Jun 30 2023)
II. Quarter |
| Y / Y Equity TTM Growth |
36.89 % |
38.61 % |
43.65 % |
46.37 % |
-36.75 % |
| Y / Y Long Term Debt TTM Growth |
-27.05 % |
-27.4 % |
- |
-12.91 % |
- |
| Long Term Debt to Equity TTM |
1.43 |
1.66 |
1.94 |
1.7 |
1.98 |
| Total
Ranking TTM |
# 48
| # 113
| # 175
| # 155
| # 174
|
| Seq. Equity TTM Growth |
-6.4 % |
-2.75 % |
3.7 % |
45.02 % |
-5.22 % |
| Seq. Long Term Debt TTM Growth |
-5.91 % |
-0.34 % |
-20.88 % |
-1.67 % |
-6.36 % |
On the trailing twelve months basis Due to long-term debt repayement of -5.91% Baxter International Inc decreased Long Term Debt to Equity in the 12 months ending in II Quarter 2024 to 1.43, above the Baxter International Inc 's average Long Term Debt to Equity. Long Term Debt to Equity is the average cumulative value over the last four quarters.
Among companies in the Medical Equipment & Supplies industry 3, during the past 12 months, other companies have achieved lower Long Term Debt to Equity than Baxter International Inc . While Long Term Debt to Equity total ranking has improved so far to 48, from total ranking in previous 12 month period at 113.
Explain Long Term Debt to Equity Ratio?
How much Long Term Debt BAX´s has?
What is the structure of BAX´s Equity?
| TTM Long Term Debt to Equity Company Ranking |
| Within: |
No. |
| Within the Medical Equipment & Supplies Industry |
# 4 |
| Healthcare Sector |
# 10 |
| Within the Market |
# 48 |
| trailing twelve months Long Term Debt to Equity Statistics |
| High |
Average |
Low |
| 1.98 |
0.7 |
0.11 | | (Jun 30 2023) |
|
(Sep 30 2019) |
| Companies with similar Long Term Debt to Equity in the quarter ending Jun 30 2024, within Medical Equipment & Supplies Industry | Long Term Debt to Equity | Jun 30 2024 MRQ Long Term Debt | Jun 30 2024 MRQ Equity | | 3m Company | 2.95 | $ 11,781.000 Millions | $ 3,988.000 Millions | | Neuronetics Inc | 2.38 | $ 46.146 Millions | $ 19.386 Millions | | Apyx Medical Corporation | 2.25 | $ 33.628 Millions | $ 14.924 Millions | | Owens and Minor inc | 2.17 | $ 1,871.800 Millions | $ 860.702 Millions | | Bioventus Inc | 1.82 | $ 344.716 Millions | $ 189.062 Millions | | Novocure Limited | 1.81 | $ 653.470 Millions | $ 361.750 Millions | | Zynex inc | 1.77 | $ 58.078 Millions | $ 32.816 Millions | | Strata Skin Sciences Inc | 1.59 | $ 15.114 Millions | $ 9.496 Millions | | Insulet Corporation | 1.36 | $ 1,359.900 Millions | $ 998.400 Millions | | Baxter International Inc | 1.35 | $ 10,436.000 Millions | $ 7,708.000 Millions | | Haemonetics Corporation | 1.35 | $ 1,218.477 Millions | $ 905.368 Millions | | Tandem Diabetes Care Inc | 1.31 | $ 307.392 Millions | $ 233.875 Millions | | Integra Lifesciences Holdings Corp | 1.12 | $ 1,723.378 Millions | $ 1,534.195 Millions | | Conmed Corporation | 1.09 | $ 965.174 Millions | $ 881.832 Millions | | Artivion Inc | 1.06 | $ 313.295 Millions | $ 295.056 Millions | | Dexcom Inc | 1.00 | $ 2,437.800 Millions | $ 2,434.300 Millions | | Cytosorbents Corporation | 0.82 | $ 13.673 Millions | $ 16.737 Millions | | P3 Health Partners Inc | 0.80 | $ 133.124 Millions | $ 166.840 Millions | | Icu Medical Inc | 0.76 | $ 1,554.822 Millions | $ 2,037.812 Millions | | Paragon 28 inc | 0.75 | $ 109.913 Millions | $ 146.835 Millions | | Integer Holdings Corporation | 0.72 | $ 1,118.529 Millions | $ 1,553.910 Millions | | Bausch and Lomb Corp | 0.70 | $ 4,602.000 Millions | $ 6,580.000 Millions | | Infusystem Holdings Inc | 0.64 | $ 34.165 Millions | $ 53.487 Millions | | Carlisle Companies Incorporated | 0.63 | $ 1,887.200 Millions | $ 3,004.300 Millions | | Merit Medical Systems Inc | 0.62 | $ 801.321 Millions | $ 1,282.445 Millions | | Dentsply Sirona Inc | 0.57 | $ 1,737.000 Millions | $ 3,064.000 Millions | | Medinotec Inc | 0.56 | $ 1.266 Millions | $ 2.250 Millions | | Medtronic Plc | 0.55 | $ 26,312.000 Millions | $ 48,160.000 Millions | | Masimo Corp | 0.55 | $ 746.500 Millions | $ 1,368.800 Millions | | Msa Safety Inc | 0.54 | $ 561.771 Millions | $ 1,033.647 Millions |
|
